Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.64 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | THRA | P10827 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL10608295 | 0.97 | SLC6A2 (0.61) | SLC6A2TAAR1LMNACYP2D6ESR1 | |
| SCHEMBL6547275 | 0.90 | CALM1 (0.57) | SLC6A2TAAR1LMNACYP2D6ESR1 | |
| SCHEMBL13889581 | 0.85 | ESR1 (0.54) | SLC6A2TAAR1LMNACYP2D6ESR1 | |
| SCHEMBL6685103 | 0.84 | ESR1 (0.74) | SLC6A2TAAR1LMNACYP2D6ESR1 | |
| SCHEMBL8002017 | 0.83 | SLC6A2 (0.58) | SLC6A2TAAR1LMNACYP2D6ESR1 | |
| SCHEMBL7297621 | 0.82 | ESR1 (0.47) | SLC6A2TAAR1LMNACYP2D6ESR1 | |
| SCHEMBL1572105 | 0.82 | SLC6A2 (0.64) | SLC6A2TAAR1LMNACYP2D6TRPA1 | |
| SCHEMBL4661772 | 0.80 | SLC6A2 (0.61) | SLC6A2TAAR1LMNACYP2D6TRPA1 | |
| SCHEMBL28358439 | 0.80 | SLC6A2 (0.61) | SLC6A2TAAR1LMNACYP2D6TRPA1 | |
| SCHEMBL28276509 | 0.79 | SLC6A2 (0.54) | SLC6A2TAAR1LMNACYP2D6ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12337304-B2 | Palladium-containing composition and hydrogen peroxide production method | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-06-24 | — | — | US | claimed |
| CN-119954987-A | Apoptosis bionic nano drug delivery carrier and preparation method and application thereof | 暨南大学 | 2025-05-09 | — | — | CN | claimed |
| CN-119431101-A | Preparation method of bis (4-tert-butylphenyl) iodonium trifluoromethane sulfonate | 沾化大荣化工科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-118290322-A | Aromatic molecules for the treatment of pathological conditions | 赛尼欧普罗有限责任公司 | 2024-07-05 | — | — | CN | claimed |
| US-20240109866-A1 | MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF | Crinetics Pharmaceuticals, Inc. | 2024-04-04 | — | — | US | claimed |
| WO-2024024508-A1 | COMPOSITION, FILM, OPTICAL FILTER, SOLID STATE IMAGING DEVICE, IMAGE DISPLAY DEVICE, INFRARED RADIATION SENSOR, AND METHOD FOR PRODUCING CAMERA MODULE | 富士フイルム株式会社 | 2024-02-01 | — | — | WO | claimed |
| CN-114276260-B | Preparation method of sun-screening agent UV A Plus | 马鞍山科思化学有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-218047942-U | Novel pipeline reactor for tert-butyl toluene | 天津鼎晟新化科技有限公司 | 2022-12-16 | — | — | CN | claimed |
| US-20220354949-A1 | NOVEL COMPOUNDS | Xeniopro GmbH (DE) | 2022-11-10 | — | — | US | claimed |
| CN-112142577-B | Metal-free catalytic oxidation system, oxygen oxidation method and production method applied to benzoic acid derivative | 浙江工业大学 | 2022-04-29 | — | — | CN | claimed |
| EP-0348464-B1 | 2-NEOPENTYLANTHRAQUINONE | BASF Aktiengesellschaft (DE) | 1993-03-31 | — | — | EP | claimed |
| US-5107004-A | 2-NEOPENTYLANTHRAQUINONE, PROCESSES FOR ITS PREPARATION AND METHODS FOR ITS USE | BASF AKTIENGESELLSCHAFT (DE) | 1992-04-21 | — | — | US | claimed |
| EP-0192492-B1 | PEPTIDES CONTAINING AN ALIPHATIC-AROMATIC KETONE SIDE CHAIN | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1992-01-02 | — | — | EP | claimed |
| EP-0244778-B1 | MONO-TERTIARY-ALKYLATED TOLUENEDIISO-CYANATES AND DERIVATIVES | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1991-10-16 | — | — | EP | claimed |
| EP-0348464-A1 | 2-NEOPENTYLANTHRAQUINONE | BASF Aktiengesellschaft (DE) | 1990-01-03 | — | — | EP | claimed |
| EP-0244778-A1 | Mono-tertiary-alkylated toluenediiso-cyanates and derivatives | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1987-11-11 | — | — | EP | claimed |
| EP-0127410-B1 | SELECTIVE CATALYTIC DEALKYLATION OF 1,4-DIALKYLBENZENE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-08-26 | — | — | EP | claimed |
| US-4608391-A | NERUOUS SYSTEM DISORDERS, PARKINSON$S DISEASE | CORNELL RESEARCH FOUNDATION INC. (US) | 1986-08-26 | — | — | US | claimed |
| US-4334115-A | ISOBUTYLENE, ISOBUTANE, ACID CATALYSTS | PHILLIPS PETROLEUM COMPANY (US) | 1982-06-08 | — | — | US | claimed |
| US-4181811-A | USING A CRYSTALLINE ALUMINA-SILICA ZEOLITE CATALYST TO PRODUCE 1,2 OR 1,3-ISOMERS | MOBIL OIL CORPORATION (US) | 1980-01-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220354949-A1 | NOVEL COMPOUNDS | MUSK, TYR, IKZF3 | SLC6A2 3872/4885TAAR1 3482/4885LMNA 3812/4885 |
| US-20240109866-A1 | MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF | MC3R, MC1R, MC2R | SLC6A2 341/4885TAAR1 247/4885LMNA 4172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.